Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The FDA approval of CAR T therapies has led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D complexities.
This application note provides:
- An outline of the complexities present in cell therapy research and development
- How Benchling’s capabilities can solve these complexities